Literature DB >> 15766674

Distinguishing features of developing natural killer cells.

Christian A J Vosshenrich1, Sandrine I Samson-Villéger, James P Di Santo.   

Abstract

Although NK cells were initially described as lymphocytes that lacked the characteristic markers of B and T cells, we now appreciate the plethora of activating and inhibitory receptors that define the NK cell surface phenotype. Recent studies have provided new insights into the molecular mechanisms that drive NK cell development, control the NK cell receptor repertoire and the cytokines that define the NK cell niche. These findings form the basis for an updated model of NK cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15766674     DOI: 10.1016/j.coi.2005.01.005

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  29 in total

1.  Resident peritoneal NK cells.

Authors:  Rosemary Gonzaga; Polly Matzinger; Ainhoa Perez-Diez
Journal:  J Immunol       Date:  2011-11-11       Impact factor: 5.422

Review 2.  Stromal-cell regulation of natural killer cell differentiation.

Authors:  Claude Roth; Carla Rothlin; Sylvain Riou; David H Raulet; Greg Lemke
Journal:  J Mol Med (Berl)       Date:  2007-04-11       Impact factor: 4.599

3.  NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery.

Authors:  Roberto Spada; José M Rojas; Sonia Pérez-Yagüe; Vladimir Mulens; Pablo Cannata-Ortiz; Rafael Bragado; Domingo F Barber
Journal:  J Leukoc Biol       Date:  2015-01-12       Impact factor: 4.962

4.  Defective natural killer cell activity in a mouse model of eczema herpeticum.

Authors:  Yuko Kawakami; Tomoaki Ando; Jong-Rok Lee; Gisen Kim; Yu Kawakami; Tae Nakasaki; Manando Nakasaki; Kenji Matsumoto; Youn Soo Choi; Toshiaki Kawakami
Journal:  J Allergy Clin Immunol       Date:  2016-07-29       Impact factor: 10.793

Review 5.  Location and cellular stages of natural killer cell development.

Authors:  Jianhua Yu; Aharon G Freud; Michael A Caligiuri
Journal:  Trends Immunol       Date:  2013-09-19       Impact factor: 16.687

6.  Overexpression of miR-155 causes expansion, arrest in terminal differentiation and functional activation of mouse natural killer cells.

Authors:  Rossana Trotta; Li Chen; Stefan Costinean; Srirama Josyula; Bethany L Mundy-Bosse; David Ciarlariello; Charlene Mao; Edward L Briercheck; Kathleen K McConnell; Anjali Mishra; Lianbo Yu; Carlo M Croce; Michael A Caligiuri
Journal:  Blood       Date:  2013-02-19       Impact factor: 22.113

7.  Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo.

Authors:  Shintaro Kamizono; Gordon S Duncan; Markus G Seidel; Akira Morimoto; Koichi Hamada; Gerard Grosveld; Koichi Akashi; Evan F Lind; Jillian P Haight; Pamela S Ohashi; A Thomas Look; Tak W Mak
Journal:  J Exp Med       Date:  2009-12-07       Impact factor: 14.307

8.  Natural killer cell cytotoxicity and immunosuppressive cytokines (IL-10, TGF-beta1) in patients with gastric cancer.

Authors:  Andrzej Szkaradkiewicz; Tomasz M Karpiński; Michał Drews; Maciej Borejsza-Wysocki; Przemysław Majewski; Ewa Andrzejewska
Journal:  J Biomed Biotechnol       Date:  2010-04-27

9.  MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response.

Authors:  Makoto Yawata; Nobuyo Yawata; Monia Draghi; Fotini Partheniou; Ann-Margaret Little; Peter Parham
Journal:  Blood       Date:  2008-06-26       Impact factor: 22.113

10.  Impaired survival of peripheral T cells, disrupted NK/NKT cell development, and liver failure in mice lacking Gimap5.

Authors:  Ryan D Schulteis; Haiyan Chu; Xuezhi Dai; Yuhong Chen; Brandon Edwards; Dipica Haribhai; Calvin B Williams; Subramaniam Malarkannan; Martin J Hessner; Sanja Glisic-Milosavljevic; Srikanta Jana; Edward J Kerschen; Soumitra Ghosh; Demin Wang; Anne E Kwitek; Ake Lernmark; Jack Gorski; Hartmut Weiler
Journal:  Blood       Date:  2008-09-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.